Kidney Health Probiotics Premix 500B - China Suppliers & Factory | Lacticaseibacillus, Bifidobacterium, Lactiplantibacillus
Deposite: CCTCC M 2020833
Shelf life: 24 months
Storage conditions: Stored at -18℃or lower
Health Benefits
Lacticaseibacillus paracasei X11
- Inhibition of renal inflammatory factors leads to a reduction in kidney inflammation;
- Enhancement of hepatic and renal tissue repair mitigates organ damage;
- Decrease in uric acid production contributes to the amelioration of hyperuricemia;
- Improvement of renal function parameters is observed.
Bifidobacterium bifidum FL-276.1
- Improvement of renal function and pathological damage;
- Enhancement of renal function parameters;
- Reduction of inflammatory cell infiltration in colonic tissue;
- Restoration of intestinal barrier integrity;
- Regulation of gut microbiota leading to an increased abundance of Akkermansia species.
Lactiplantibacillus plantarum F3-2
- Lowering triglyceride and total cholesterol levels in the blood;
- Reducing lipid accumulation;
- Improving lipid metabolism;
- And preventing complications of kidney disease.
Bifidobacterium animalis subsp.lactis BA-C53
- Good product stability;
- Regulates intestinal flora imbalance, improves immunity;
- Restores intestinal microecology.
Probiotics: A new breakthrough for kidney health
In recent years, as the role of gut microbiota in disease has been increasingly recognized, a growing body of research indicates that the development and progression of chronic kidney disease (CKD) is often accompanied by dysbiosis of the gut microbiota and its metabolic products, as well as impaired intestinal barrier function. Therefore, metabolic regulation based on gut microbiota and its metabolites holds significant potential for intervening in the progression of chronic kidney disease.
Probiotics: Improving intestinal flora for kidney health
The advancements presented at the 61st European Renal Association Congress indicate that probiotics represent an effective, safe, and cost-efficient therapeutic approach. This intervention can enhance the gut microbiota in patients with chronic kidney disease (CKD), reduce levels of uremic toxins, mitigate inflammatory responses, and decrease the severity of fatty liver, as well as lower glucose tolerance tests (GTT) and alleviate constipation.
As a safe, effective, and economical treatment option, probiotics offer a promising strategy for promoting renal health.
FL-276.1 Improvement of intestinal barrier damage
F3-2 lowers blood lipids and prevents complications of kidney disease
